Hospital procurement and supply chain teams evaluating new medical technologies
New: Manufacturing Quotes — source from manufacturers in 35 countries.Start a Project
For hospitals and health systems
Evaluate medical technologies with structured market intelligence
Evaluate medical technologies with structured source intelligence — regulatory status, reimbursement pathways, and clinical evidence organised before procurement decisions.
Workspace access is invite-only. Market-access content requires professional review before business use.
Who this is for
Clinical department heads assessing devices for pilot adoption
Health system market access officers managing multi-country procurement
Hospital administrators overseeing regulatory and tender compliance
Problems GHMAP helps with
Assessing whether a new device is approved and reimbursed in your jurisdiction
Evaluating manufacturer regulatory compliance before procurement
Tracking clinical evidence status and evidence gaps for pilot technologies
Comparing devices across regulatory pathway complexity and payer coverage
Managing multi-vendor evaluations with structured source documentation
What GHMAP organizes
GHMAP keeps market-access records and open questions structured for review, tracking, and handoff.
Countries
Products
Stakeholders
Regulatory questions
Reimbursement questions
Evidence gaps
Source status
Review status
Next actions
Meeting and request tracking
Example workflow
- 1
Submit a technology evaluation request with device category and target market
- 2
GHMAP structures regulatory status, reimbursement pathway, and payer landscape
- 3
Source governance tracks whether information is verified, reviewed, or pending
- 4
Professional review flags where clinical or regulatory expert input is required
- 5
Structured evaluation brief produced for procurement or pilot decision
What happens after request
The requester receives a reference number.
The requester receives an email when email delivery is configured.
The request can be tracked through Track Request using the reference number and matching email.
GHMAP reviews fit and may request additional information.
Workspace access remains invite-only and reviewed.
Safety boundaries
GHMAP supports market-access intelligence and professional review.
It does not provide diagnosis, treatment advice, legal advice, regulatory approval, reimbursement guarantees, investment advice, or market-entry guarantees.
Request reviewed access
Start your market access project ashospitals & health systems.
Use the request-demo flow to share role, organization, product or sector interest, countries, and objective. GHMAP will review fit before any workspace access.